Table 2:
Intraprocedural findings of endovascular treatment modalities and access sites.
| Variables | RA+DCB (n=50) | DCB (n=53) | p-value | Popliteal (n=46) | Femoral (n=57) | p-value |
|---|---|---|---|---|---|---|
| Lesion characteristics | ||||||
| Right SFA (%) | 23 (46) | 27 (50.9) | 0.62 | 22 (47.8) | 28 (49.1) | 0.62 |
| Length, cm | 15.65±7.43 | 12.63±9.23 | 0.07 | 18.70±7.05 | 10.38±7.76 | 0.001 |
| Proximal diameter, mm | 4.56±1.00 | 4.85±0.96 | 0.14 | 4.98±0.96 | 4.49±0.96 | 0.03 |
| Distal diameter, mm | 4.28±0.99 | 4.09±0.89 | 0.26 | 4.27±1.07 | 4.01±0.92 | 0.05 |
| TASC-II (%) | ||||||
| Type A | 5 (10) | 12 (22.6) | 0.05 | 3 (6.5) | 14 (24.6) | 0.001 |
| Type B | 12 (24) | 20 (37.7) | 4 (8.7) | 28 (49.1) | ||
| Type C | 16 (32) | 9 (17) | 18 (39.1) | 7 (12.3) | ||
| Type D | 17 (34) | 12 (22.6) | 21 (47.5) | 8 (14) | ||
| PACSS Score (≥3) (%) | 11 (22) | 16 (30.2) | 0.35 | 9 (19.6) | 18 (31.6) | 0.17 |
| Kockelkoren score (<7) (%) | 41 (82) | 41 (77.4) | 0.56 | 36 (78.3) | 46 (80.7) | 0.76 |
| Intraprocedural (%) | ||||||
| Access*/Atherectomy | 26 (52) | 20 (37.7) | 0.15 | 26 (56.5) | 24 (42.1) | 0.15 |
| Dissection | 42 (84) | 39 (73.6) | 0.20 | 39 (84.8) | 42 (73.7) | 0.17 |
| DISFORM* (%) | ||||||
| Group A | 27 (64.3) | 25 (64.1) | 0.98 | 24 (61.5) | 28 (66.7) | 0.63 |
| Group B | 15 (35.7) | 14 (35.9) | 15 (38.5) | 14 (33.3) | ||
| Bailout Stenting (%) | 5 (10) | 4 (7.5) | 0.74 | 2 (3.5) | 7 (15.2) | 0.07 |
| Distal Embolization (%) | 3 (6) | 0 (0) | 0.11 | 1 (1.8) | 2 (4.3) | 0.59 |
Femoral puncture is including cross procedures, *DISFORM: Diameter reduction, spiral shape, flow impairment, or adverse morphology, TASC: Trans-Atlantic Inter-Society Consensus, PACSS: The peripheral artery calcification scoring system, Kockelkoren Score; <7 intimal dominant, ≥7 non-intimal dominant plaque formation. SFA: Superficial femoral artery, CTO: Chronic total occlusion, RA: Rotational atherectomy, DCB: Drug coated balloon, Statistical significance was defined as p < 0.05. Continuous variables are presented as mean ± standard deviation